Pacira BioSciences, Inc. Common Stock (PCRX) is a publicly traded Healthcare sector company. As of October 30, 2026, PCRX trades at $36.40 with a market cap of $1.45B and a P/E ratio of 71.10. PCRX moved +0.00% today. Year to date, PCRX is +44.98%; over the trailing twelve months it is +73.20%. Its 52-week range spans $18.80 to $36.67. Analyst consensus is neutral with an average price target of $34.79. Rallies surfaces PCRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for PCRX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $36.40 |
| Market Cap | $1.45B |
| P/E Ratio | 71.10 |
| EPS | $0.35 |
| Dividend Yield | 0.00% |
| 52-Week High | $36.67 |
| 52-Week Low | $18.80 |
| Volume | 176.40K |
| Avg Volume | 0 |
| Revenue (TTM) | $746.16M |
| Net Income | $14.64M |
| Gross Margin | 79.21% |
9 analysts cover PCRX: 0 strong buy, 0 buy, 9 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $34.79.